Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
London, UK / Paris, France. Exclusive To Gareth Lee – This Position Is Not Available Via Another Recruiter. Global Pharmaceutical company, Rare Disease portfolio. Location: (Hybrid with 2-3 days per week required in the office). Salary: Up to £120k plus package. This is a new, rare disease focused Global position within the HEOR & Market Access team of a major … Read more
Montreal, Canada. Key Responsibilities: Developing market access, health economics & outcomes research strategies to gain / maintain / optimize reimbursement for new and existing products with various public and private payers; Developing submissions dossiers for CADTH, INESSS and private payers, including the development of budgetary impact analyses and the development/adaptation of economic analyses. This requires: Liaising with the global market … Read more
Amsterdam, Netherlands. Health Economics and Value Assessment (HEVA) Business Partner – VIE Contract. Location: Netherlands, Amsterdam. Target start date: 01/02/2025. iMove, the Sanofi VIE Program, is available to citizens of the European Economic Area (EU + Norway, Liechtenstein and Iceland) aged between 18 and 28. PLEASE NOTE that since this program is primarily an international development program, candidates cannot apply … Read more
Santo Amaro, Brazil. Leads the development and implementation of the patient accessstrategy at (large) country / regional level. To facilitate and achieve optimal Patient Access by building relationships with keyinfluencers and decision-makers at a local level. About the Role: Key responsibilities: Be part of the brand core value team, working closely with PM and MA to co-create the brand strategy. … Read more
Seoul, South Korea. Are you passionate about driving strategic initiatives and programs in the field of Real World Evidence (RWE)? Do you have experience in managing teams and engaging with stakeholders? If so, we have an exciting opportunity for you to join our Clinical, Medical, Regulatory Affairs (CMR) department as a Real World Evidence Manager. Read on to learn more … Read more
UK / Belgium / US. The role of Associate Director, Global Real-World Evidence & Health Outcomes Research, Evidence Synthesis is critical to achieving this ambition by ensuring that each medicine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing. Associate Director, Evidence Synthesis works in … Read more
NJ / CA, US + other States. Johnson & Johnson Innovative Medicine is recruiting for Senior Director, R&D Data Science and Digital Health, Real-World Evidence and Advanced Analytics Other locations: Titusville, NJ; San Diego, CA; Spring House,, PA; Cambridge, MA; New Brunswick, NJ; South San Francisco, CA, US. The Data Science and Digital Health Analytics & Insights team within Johnson … Read more
Tokyo, Japan. Implements a global to local network providing RWE guidance and frameworks for Japanese affiliates, guiding translation of business questions into scientific sound approaches.Designs and leads a network approach for colleagues working in the Evidence generation space and ensures maximum transparency and synergies.Ensures a common understanding of RWE generation methods and strategies in Japan for various stakeholders, including patients, … Read more
Beijing, China. Value Access organization aims to establish long-term partnership with HCS stakeholders, systematically generate customer insights, maximize patient access, drive self-pay to reimbursement working with public and private stakeholders. We are looking for a HEOR and Access Strategy Senior Manager who will be responsible for the development and tactical execution of market access and pricing strategy for CV products. … Read more
Waltham, MA, US. Sobi is currently recruiting for a Director, HEOR and RWE, to join our growing Health Economic and Outcomes Research/Real-World Evidence (HEOR/RWE) team within the Medical Affairs department. In this position, the individual will be responsible for leading HEOR and RWE scientific strategy, evidence generation, and dissemination plans for Sobi’s North America disease portfolios. This position is remote, … Read more
Shanghai / Beijing, China. As part of the industry-leading global RWE solution, the IQVIA China Real-World Solution team is a young, energetic and fast-growing team consists of master and PhD level researchers/consultants, with strong academic background and working experience in economic modeling, value-evidence strategy & communication, value dossiers, network meta-analyses, and real-world studies either based on chart review or database analysis. … Read more
UK / Netherlands / US. As the Director, Pipeline Immunology Asset Lead – ImmunoOncology, GHEVO, you’ll serve as a principal strategic and technical GHEVO lead for immunology compounds in development. Collaborating closely with cross-functional teams, you will guide health economics, value, and outcomes research to support the value proposition of our immunology assets, shaping global strategies that impact patient lives. … Read more
Hoeilaart, Belgium. We look for a passionate professional to join our Belgium’s Healthcare Leadership team as Head of Market Access, Pricing and Government Affairs director based in Brussels. The key purpose of the role is (1) to expand access and optimize pricing for our Healthcare portfolio in Belgium and in Luxembourg, (2) to engage stakeholders in Belgium’s and Luxembourg’s Healthcare … Read more
Soeborg, Denmark. The candidate will be responsible for executing market access strategies and managing tenders to ensure the successful commercialisation of our Healthcare products. The role involves collaborating with internal teams and external stakeholders to navigate regulatory and reimbursement landscapes, optimise pricing, and secure favourable prices and access. This position requires an understanding of healthcare systems, tendering process, and health … Read more
Petaling Jaya, Malaysia / Bangkok, Thailand. Provides high quality, timely development and on-time input to client solutions for the pharmaceutical and related industries. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Other locations: Jakarta, Indonesia; Remote, Malaysia. Principal Accountabilities: Minimum Education, Experience Required: This job ad … Read more
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Toujours activé
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.